Backs the trader's plan in full — the first tranche at 741 with a 697 stop and 786.52 target is disciplined aggression, not a chase. Calls waiting for a deeper pullback "paralysis": the VWMA and 10 EMA are rising fast, and support is coming to meet the price.
Argues the 697 stop is the correct structural line (just under VWMA), not a textbook 2×ATR stop, and that the second tranche at 715–720 brings the blended risk/reward to roughly 1.9:1 — passivity is the bigger risk in the room.
Agrees the tape has changed character and the trader's instinct to participate is correct, but calls the first tranche's 1:1 reward/risk a "coin flip" that should be sized as a probe (one-quarter), not one-third to one-half.
Proposes a resting order at 738–741 (small), a second at 715–720 only on stabilization with declining volume, and a final tranche only after golden-cross confirmation plus a retest — capping risk at ~1% of portfolio at the 697 stop.
Rejects the 741.25 buy outright: entry-to-stop risk (44 pts) is roughly equal to reward-to-target (45 pts) — a coin flip, not an asymmetric trade — and the 736–746 "shelf" is an untested one-day gap area, not real support.
Wants a resting limit at 715–720 instead, same 697 stop and 786.52 target, sized at no more than one-third of a position; if it never fills, missing the move is acceptable — capital preservation comes first.
Thesis: Direction is bullish, but the entry is stretched — that asymmetry maps to Overweight, not Buy or Sell. The bull case is genuinely strong: revenue acceleration to +28% YoY, record Q2 operating cash flow ($31.9B), a confirmed technical regime change (MACD 42.93 vs. signal 31.20, 200 SMA inflecting to 625.42, a Sept 21 breakout on 48.7M shares followed by a Sept 25 pullback on only 25.8M shares), and a credible re-rating catalyst in the Muse AI agent plus Wells Fargo's target raise to $796. But the conservative objections land hard and are unrebutted: net income fell 14% and EPS fell 13% despite the revenue growth, FCF collapsed to $1.75B against $30.1B of quarterly capex, debt doubled to $112B with buybacks paused for three quarters, and a fresh New Mexico jury verdict plus the October 9 documentary are near-term negatives. The neutral analyst's math is decisive: entry 741 / stop 697 / target 786.52 is roughly 1:1, not the asymmetry claimed — and the conservative's preferred 715–720 entry with the same 697 stop is also flawed, since an 18–23 point stop is less than one ATR (27.21) and would likely be shaken out by noise.
Action: Build META exposure gradually, not at market ($751.66) — place a small first tranche (one-quarter to one-third of a standard position) as a resting limit in the 736–741 breakout shelf, a second tranche at 715–720 only on stabilization with declining volume, and cap total size below the August norm (ATR 27.21). Exit or reassess on a daily close below 698 (VWMA) on above-average volume; first target 786.52 (upper Bollinger), with upside extension only if 786 is broken on strong volume. What would change the call: a Q3 print showing capex guidance stepping up again while net income keeps declining pauses accumulation; a golden cross (50 SMA above 200 SMA near 615–625), a high-volume close above 786.52, or a successful retest of the breakout shelf are the signals to complete the Overweight allocation. Time horizon: 3–6 months.